Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
SSE:688505
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
Revenue
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
S
|
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
SSE:688505
|
Revenue
¥850.7m
|
CAGR 3-Years
1%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Revenue
¥10.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Revenue
¥9.7B
|
CAGR 3-Years
14%
|
CAGR 5-Years
16%
|
CAGR 10-Years
22%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Revenue
¥22.3B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
7%
|
CAGR 10-Years
14%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Revenue
¥39.1B
|
CAGR 3-Years
6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
9%
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Revenue
¥2.5B
|
CAGR 3-Years
24%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
See Also
What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd's Revenue?
Revenue
850.7m
CNY
Based on the financial report for Dec 31, 2023, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd's Revenue amounts to 850.7m CNY.
What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd's Revenue growth rate?
Revenue CAGR 5Y
3%
Over the last year, the Revenue growth was -17%. The average annual Revenue growth rates for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd have been 1% over the past three years , 3% over the past five years .